ATE278415T1 - Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum - Google Patents

Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Info

Publication number: ATE278415T1
Authority: AT; Austria
Prior art keywords: growth factor; epidermal growth; egf; animal; preparing
Prior art date: 1995-05-10

Application number

AT00123426T

Other languages

English (en)

Inventor

Andre G Buret

James A Hardin

Grant D Gall

Merle E Olson

Original Assignee

Univ Technologies Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-10

Filing date

1996-05-09

Publication date

2004-10-15

1996-05-09 Application filed by Univ Technologies Int filed Critical Univ Technologies Int

2004-10-15 Application granted granted Critical

2004-10-15 Publication of ATE278415T1 publication Critical patent/ATE278415T1/de

Links

VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title abstract 4
102000009024 Epidermal Growth Factor Human genes 0.000 title abstract 3
101800003838 Epidermal growth factor Proteins 0.000 title abstract 3
229940116977 epidermal growth factor Drugs 0.000 title abstract 3
230000002496 gastric effect Effects 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 2
208000000103 Anorexia Nervosa Diseases 0.000 abstract 1
239000000654 additive Substances 0.000 abstract 1
230000000996 additive effect Effects 0.000 abstract 1
238000009360 aquaculture Methods 0.000 abstract 1
244000144974 aquaculture Species 0.000 abstract 1
239000003651 drinking water Substances 0.000 abstract 1
235000020188 drinking water Nutrition 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000002778 food additive Substances 0.000 abstract 1
235000013373 food additive Nutrition 0.000 abstract 1
208000015380 nutritional deficiency disease Diseases 0.000 abstract 1
230000004584 weight gain Effects 0.000 abstract 1
235000019786 weight gain Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Animal Husbandry (AREA)
Food Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Birds (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Oncology (AREA)
Child & Adolescent Psychology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Fodder In General (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT00123426T 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum ATE278415T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/438,901 US5753622A (en)	1995-05-10	1995-05-10	Use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number	Publication Date
ATE278415T1 true ATE278415T1 (de)	2004-10-15

Family

ID=23742496

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT00123426T ATE278415T1 (de)	1995-05-10	1996-05-09	Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum
AT04019831T ATE357927T1 (de)	1995-05-10	1996-05-09	Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier
AT96913397T ATE203912T1 (de)	1995-05-10	1996-05-09	Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AT04019831T ATE357927T1 (de)	1995-05-10	1996-05-09	Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier
AT96913397T ATE203912T1 (de)	1995-05-10	1996-05-09	Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Country Status (12)

Country	Link
US (2)	US5753622A (de)
EP (3)	EP1479394B1 (de)
JP (1)	JP3549541B2 (de)
AT (3)	ATE278415T1 (de)
AU (1)	AU704675B2 (de)
CA (2)	CA2220434C (de)
DE (3)	DE69614377T2 (de)
DK (3)	DK0824357T3 (de)
ES (2)	ES2226681T3 (de)
NZ (2)	NZ307134A (de)
PT (1)	PT1479394E (de)
WO (1)	WO1996035445A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5753622A (en) *	1995-05-10	1998-05-19	University Technologies International, Inc.	Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) *	1998-05-13	1999-07-27	Carrington Laboratories, Inc.	Aloe pectins
US7022683B1 (en)	1998-05-13	2006-04-04	Carrington Laboratories, Inc.	Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6313103B1 (en)	1998-05-13	2001-11-06	Carrington Laboratories, Inc.	Pectic substance as a growth factor stabilizer
US20060014684A1 (en) *	2000-03-03	2006-01-19	University Technologies International Inc.	Novel uses of EGF
US7494669B2 (en)	2001-02-28	2009-02-24	Carrington Laboratories, Inc.	Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
JP2004536589A (ja) *	2001-05-18	2004-12-09	カナダ国	ウシ上皮成長因子の核酸及びタンパク質配列
CA2464609A1 (en) *	2001-10-26	2003-05-01	University Technologies International, Inc.	Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) *	2002-04-30	2003-10-30	Alberta Research Council Inc.	Production of recombinant epidermal growth factor in plants
JP2005529622A (ja)	2002-06-19	2005-10-06	ヴェーイーベー・ヴェーゼットウェー	腸吸収を促進するための方法および手段
JP2008514651A (ja) *	2004-09-30	2008-05-08	ユニバーシティー・テクノロジーズ・インターナショナル・インコーポレイテッド	上皮増殖因子（ｅｇｆ）を含んで成る再水和組成物
US8703769B2 (en) *	2005-07-15	2014-04-22	The University Of North Carolina At Chapel Hill	Use of EGFR inhibitors to prevent or treat obesity
ES2405552T3 (es)	2005-11-29	2013-05-31	Actogenix N.V.	Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
WO2008090223A2 (en)	2007-01-25	2008-07-31	Actogenix N.V.	Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
US20110275566A1 (en) *	2008-10-10	2011-11-10	Nationwide Children's Hospital Inc.	Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) *	2012-06-20	2013-07-31	湖南海谷生物技术有限公司	一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) *	2017-01-26	2022-02-08	Washington University	Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) *	2021-11-09	2023-09-22	浙江省农业科学院	用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8409960D0 (en) *	1984-04-17	1984-05-31	Searle & Co	Therapeutic method
EP0292517B1 (de) *	1986-12-11	1992-09-09	Btg International Limited	Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf
ATE161181T1 (de)	1992-07-06	1998-01-15	Nestle Sa	Lactobacillus acidophilus enthaltende antigastritis-mittel
US5753622A (en) *	1995-05-10	1998-05-19	University Technologies International, Inc.	Use of epidermal growth factor as a gastrointestinal therapeutic agent

1995
- 1995-05-10 US US08/438,901 patent/US5753622A/en not_active Expired - Lifetime
1996
- 1996-05-09 AT AT00123426T patent/ATE278415T1/de not_active IP Right Cessation
- 1996-05-09 EP EP04019831A patent/EP1479394B1/de not_active Expired - Lifetime
- 1996-05-09 NZ NZ307134A patent/NZ307134A/en not_active IP Right Cessation
- 1996-05-09 DE DE69614377T patent/DE69614377T2/de not_active Expired - Fee Related
- 1996-05-09 JP JP53362496A patent/JP3549541B2/ja not_active Expired - Fee Related
- 1996-05-09 DE DE69633583T patent/DE69633583T2/de not_active Expired - Fee Related
- 1996-05-09 NZ NZ501482A patent/NZ501482A/xx not_active IP Right Cessation
- 1996-05-09 WO PCT/CA1996/000291 patent/WO1996035445A1/en not_active Ceased
- 1996-05-09 PT PT04019831T patent/PT1479394E/pt unknown
- 1996-05-09 EP EP96913397A patent/EP0824357B1/de not_active Expired - Lifetime
- 1996-05-09 AT AT04019831T patent/ATE357927T1/de not_active IP Right Cessation
- 1996-05-09 DK DK96913397T patent/DK0824357T3/da active
- 1996-05-09 CA CA002220434A patent/CA2220434C/en not_active Expired - Fee Related
- 1996-05-09 DE DE69637002T patent/DE69637002T2/de not_active Expired - Fee Related
- 1996-05-09 EP EP00123426A patent/EP1092437B1/de not_active Expired - Lifetime
- 1996-05-09 DK DK00123426T patent/DK1092437T3/da active
- 1996-05-09 DK DK04019831T patent/DK1479394T3/da active
- 1996-05-09 AT AT96913397T patent/ATE203912T1/de not_active IP Right Cessation
- 1996-05-09 AU AU56411/96A patent/AU704675B2/en not_active Ceased
- 1996-05-09 CA CA2492724A patent/CA2492724C/en not_active Expired - Fee Related
- 1996-05-09 ES ES00123426T patent/ES2226681T3/es not_active Expired - Lifetime
- 1996-05-09 ES ES04019831T patent/ES2285320T3/es not_active Expired - Lifetime
2000
- 2000-03-03 US US09/518,135 patent/US6656907B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6656907B1 (en)	2003-12-02
AU704675B2 (en)	1999-04-29
AU5641196A (en)	1996-11-29
DK1092437T3 (da)	2005-01-31
DE69633583T2 (de)	2006-02-23
HK1072894A1 (en)	2005-09-16
CA2220434C (en)	2005-02-22
DK1479394T3 (da)	2007-06-11
CA2492724C (en)	2010-08-03
CA2220434A1 (en)	1996-11-14
ES2285320T3 (es)	2007-11-16
DE69614377D1 (de)	2001-09-13
DE69614377T2 (de)	2002-05-23
EP1092437B1 (de)	2004-10-06
EP0824357A1 (de)	1998-02-25
US5753622A (en)	1998-05-19
DE69633583D1 (de)	2004-11-11
CA2492724A1 (en)	1996-11-14
DK0824357T3 (da)	2001-10-08
WO1996035445A1 (en)	1996-11-14
EP0824357B1 (de)	2001-08-08
PT1479394E (pt)	2007-04-30
NZ501482A (en)	2004-12-24
DE69637002D1 (de)	2007-05-10
ATE357927T1 (de)	2007-04-15
DE69637002T2 (de)	2007-08-16
ES2226681T3 (es)	2005-04-01
JP3549541B2 (ja)	2004-08-04
ATE203912T1 (de)	2001-08-15
EP1092437A1 (de)	2001-04-18
JPH11505528A (ja)	1999-05-21
NZ307134A (en)	2000-02-28
EP1479394A1 (de)	2004-11-24
EP1479394B1 (de)	2007-03-28

Legal Events

Date

Code

Title

Description

2005-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1092437

Country of ref document: EP

2010-02-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE203912T1 (de)	2001-08-15	Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum
GR3006124T3 (de)	1993-06-21
AU2118488A (en)	1989-02-23	Improvements in or relating to methods of treating damaged skin
AU1277688A (en)	1988-09-08	Sustained release compositions for parenteral administration and their use
ATE283241T1 (de)	2004-12-15	Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE3681144D1 (de)	1991-10-02	Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
DE69130497D1 (de)	1998-12-24	Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE59505618D1 (de)	1999-05-20	Orale Verwendung von Calciumformiat zur Behandlung von Calciumdefizienz bei Tieren
ATE47274T1 (de)	1989-11-15	Tierstreu sowie verfahren zur herstellung derselben.
DE68903907D1 (de)	1993-01-28	Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE8049T1 (de)	1984-07-15	1,3-dioxan-5-yl-alkyltriazole, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer.
DE3686559D1 (de)	1992-10-01	Verwendung von phenaethanolaminen zum verbessern des fettgehaltes von saumilch.
JPS5729270A (en)	1982-02-17	Preparation of nonheat-coagulable egg white
DE69313850D1 (de)	1997-10-16	Veterinaerprodukt zur rehydration
ATE173921T1 (de)	1998-12-15	Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ATE84194T1 (de)	1993-01-15	Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
IT1232818B (it)	1992-03-05	Impiego dell'acido piperazin carbossilico e suoi derivati per il trattamento di ridotto spirito di iniziativa e/o ritrosia sociale, disturbi di sonno o emicrania e simili
Royston	1988	Formation, function and potential relevance in anaesthesia.
ATE124264T1 (de)	1995-07-15	Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen.
ATE246932T1 (de)	2003-08-15	Methode zur herstellung eines wirkstoffes zur behandlung von ulcera des organismus
MD512C2 (ro)	1996-11-30	Inhibitor dezvoltării mugurilor la altoaiele viţei de vie
ATE155479T1 (de)	1997-08-15	Neue cytarabin-derivate, ihre herstellung und verwendung
UA13500A (uk)	1997-04-25	Спосіб запобігання негативному впливу магнітних бур на організм лактуючих корів